Kenneth Ward, M.D. – Founder and CEO

Kenneth Ward, MD is internationally known in the field of Medical Genetics and also a prominent high-risk pregnancy specialist. Dr. Ward is one of the only physicians in the United States who is Board-certified in four specialties including Obstetrics and Gynecology, Maternal-Fetal Medicine, Medical Genetics, and Molecular Genetics.

During his academic career, Dr. Ward founded and directed the University of Utah DNA Diagnostic Laboratory and the Molecular Genetics Laboratory at ARUP. Dr. Ward has over 30 years experience in DNA diagnostics and he has launched over a dozen “first-use-in-human” tests. He created the University of Utah’s training program in Clinical Molecular Genetics and he supervised the perinatal genetic counseling program. Dr. Ward led the efforts to map a number of human disease genes; his research has also focused on pregnancy-related complications including the genetics of preterm birth and preeclampsia. Dr. Ward also served as the Chairman of the Department of Obstetrics, Gynecology, and Women’s Health at the University of Hawaii.

Dr. Ward has published over one hundred peer-reviewed papers and dozens of book chapters and scientific papers. He has authored over 250 scientific abstracts presented at national and international scientific meetings. He is an inventor on several issued and over forty pending patent applications.

Most recently, Dr. Ward has founded, grown and operated a number of successful biotechnology companies. He has raised over $100 million in grant, angel, venture, and strategic financings. He serves as Laboratory Director of the CLIA lab at Taueret Laboratories. In his present role at Juneau Biosciences, he leads the development of novel predictive DNA-based tests for endometriosis.

View Dr. Kenneth Ward’s CV (PDF)

Hans Albertsen, P h.D. – Chief Scientific Officer

Dr. Albertsen, Ph.D., joined Juneau Biosciences at its inception in April 2007. Hans received his Ph.D. degree from the University of Aarhus, Denmark and has over 20 years of experience in human genetic research in both commercial and academic settings. He has authored over 35 articles primarily in the areas of genetic mapping, physical mapping, positional cloning and gene expression profiling. Dr. Albertsen has been on the faculty of the Departments of Human Genetics and Family and Preventive Medicine at the University of Utah. He has also worked as Program Manager of Microarrays at Amersham Pharmacia Biotech in Sunnyvale, CA. Hans is listed as an inventor on six patents.